About admin

This author has not yet filled in any details.
So far admin has created 13 blog entries.

ImaginAb Closes $8 million New Funding to Accelerate Clinical Development of CD8 ImmunoPET Agent

By |2018-10-26T23:20:42+00:00October 9th, 2017|

ImaginAb has raised an additional $8 million in new equity funding led by Adage Capital. The company’s shareholders also include the Parker Institute for Cancer Immunotherapy, NVF, Cycad Group, Nextech Invest, and Jim Pallotta of the Raptor Group.

ImaginAb Inc. Announces Strategic Collaboration with Boehringer Ingelheim to Develop New Technology for Monitoring Anti-tumor Activity of the Immune System

By |2018-10-26T23:19:17+00:00September 25th, 2017|

ImaginAb announced today a collaboration with Boehringer Ingelheim, one of the world’s 20 leading pharmaceutical companies, to further develop ImaginAb’s CD8 T Cell imaging technology.